Are you Dr. Wilson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
20 York St Np4
New Haven, CT 06510Phone+1 203-200-5864Fax+1 203-688-3501
Summary
- Dr. Frederick Wilson, MD is an oncologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Massachusetts. He is affiliated with Yale-New Haven Hospital.
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
- Harvard Medical SchoolClass of 2007
Certifications & Licensure
- CT State Medical License 2017 - 2024
- MA State Medical License 2009 - 2017
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1088 citationsHuman hypertension caused by mutations in WNK kinasesFrederick H. Wilson, Sandra Disse-Nicodeme, Keith A. Choate, Kazuhiko Ishikawa, Carol Nelson-Williams
Science. 2001-08-10 - 133 citationsWNK4 regulates apical and basolateral Cl– flux in extrarenal epitheliaKristopher T. Kahle, Ignacio Gimenez, Hatim Hassan, Frederick H. Wilson, Robert D. Wong
Proceedings of the National Academy of Sciences of the United States of America. 2004-02-17 - 306 citationsPembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.Sarah B. Goldberg, Kurt A. Schalper, Scott N. Gettinger, Amit Mahajan, Roy S. Herbst
The Lancet. Oncology. 2020-05-01